RI's Plan to Conform with the FDA Manufactured Food Regulatory Program Standards

拨款建议摘要 符合制造食品监管计划标准（MFRPS） （U18）。融资机会公告编号（FOA）：RFA-FD-12-007 国际扶轮卫生部食品保护办公室建议发展并维持一个 根据国家标准，在RI实施基于风险的制成品监管计划。 该方案将以最佳做法为基础，并在五年后符合 FDA制造食品监管计划标准（MFRPS）。最终，这将减少 RI食品生产设施中食源性疾病的风险。 粮食保护办公室的一名合规和评价干事将负责 在主要研究者的指导下管理MFRPS，并确保符合性 与国家计划标准的十个要素，其中包括：计划的 监管基础、员工培训、检查、质量保证、食品防御准备 食源性疾病和事件调查、执法、教育和 外展、资源管理、项目评估和实验室资源。 实现所有MFRPS的五年计划包括年度评估和战略更新， 根据成绩、进度报告、所需书面文件的编写 程序，持续培训，改进数据管理，实施所有 十项标准的要求，并符合FDA的审计和发展， 内部审计，以确保持续的质量改进和长期遵守所有 标准 国际扶轮卫生部也将致力于提高与联邦伙伴的透明度，并尽一切努力 当州或FDA发现问题时，为最佳监管行动提供基础。 国家打算支持FDA的努力，并相信国家和FDA将 从伙伴关系中受益。

Grant Proposal Abstract Title: Conformance with the Manufactured Food Regulatory Program Standards (MFRPS) (U18). Funding Opportunity Announcement Number (FOA): RFA-FD-12-007 The RI Department of Health, Office of Food Protection proposes to develop and maintain a risk-based manufactured food regulatory program in RI in conformance with national standards. This program will be based on best practices, and, at the end of five years, will conform to the FDA Manufactured Food Regulatory Program Standards (MFRPS). Ultimately this will reduce the risk of foodborne disease in food manufacturing facilities in RI. A Compliance and Evaluation Officer in the Office of Food Protection will be responsible for managing the MFRPS under the direction of the Principal Investigator and ensure conformance with the ten elements of the national program standards, which include: the program's regulatory foundation, staff training, inspection, quality assurance, food defense preparedness and response, foodborne illness and incident investigation, enforcement, education and outreach, resource management, program assessment, and laboratory resources. The five year plan to meet all MFRPS includes yearly assessment and updates to the strategic plan based upon accomplishments, progress reports, development of required written procedures, continuous training, improvement of data management, implementation of all requirements for the ten standards, and compliance with FDA audits and development of internal auditing to assure continuous quality improvement and long term compliance with all standards. The RI DOH will also aim to enhance transparency with federal partners and make every effort to provide a foundation for optimal regulatory action when the State or FDA identifies problems. The State intends to support FDA's efforts and is confident that both the State and FDA will benefit from the partnership.